Ranjan Pai, as a partner at Aarin Capital, invests in early to growth-stage technology-intensive startups. See portfolio, sector focus and contact routes.
Ranjan Pai, as a partner at Aarin Capital, invests in early to growth-stage technology-intensive startups, primarily in life sciences, healthcare, and education, with a distinctive thesis focused on large India-centric or India-first market opportunities. The firm typically deploys checks between $500,000 and $10 million, often targeting Series A companies. Notable portfolio companies include Vyome Biosciences (now Vyome Therapeutics), Think & Learn (Byju’s), FabHotels, Theramyt Novobiologics, and CourseMaster.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Bangalore.
Investors like Ranjan Pai · Full investor directory · Investor access · Company funding database